<!DOCTYPE html>
<html lang="en"><head>
<script src="index_files/libs/clipboard/clipboard.min.js"></script>
<script src="index_files/libs/quarto-html/tabby.min.js"></script>
<script src="index_files/libs/quarto-html/popper.min.js"></script>
<script src="index_files/libs/quarto-html/tippy.umd.min.js"></script>
<link href="index_files/libs/quarto-html/tippy.css" rel="stylesheet">
<link href="index_files/libs/quarto-html/light-border.css" rel="stylesheet">
<link href="index_files/libs/quarto-html/quarto-html.min.css" rel="stylesheet" data-mode="light">
<link href="index_files/libs/quarto-html/quarto-syntax-highlighting-dark.css" rel="stylesheet" id="quarto-text-highlighting-styles"><meta charset="utf-8">
  <meta name="generator" content="quarto-1.3.450">

  <meta name="author" content="Christopher Shin">
  <title>Treat-to-Target or High-Intensity Statin in Coronary Artery Disease</title>
  <meta name="apple-mobile-web-app-capable" content="yes">
  <meta name="apple-mobile-web-app-status-bar-style" content="black-translucent">
  <meta name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=1.0, user-scalable=no, minimal-ui">
  <link rel="stylesheet" href="index_files/libs/revealjs/dist/reset.css">
  <link rel="stylesheet" href="index_files/libs/revealjs/dist/reveal.css">
  <style>
    code{white-space: pre-wrap;}
    span.smallcaps{font-variant: small-caps;}
    div.columns{display: flex; gap: min(4vw, 1.5em);}
    div.column{flex: auto; overflow-x: auto;}
    div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
    ul.task-list{list-style: none;}
    ul.task-list li input[type="checkbox"] {
      width: 0.8em;
      margin: 0 0.8em 0.2em -1em; /* quarto-specific, see https://github.com/quarto-dev/quarto-cli/issues/4556 */ 
      vertical-align: middle;
    }
  </style>
  <link rel="stylesheet" href="index_files/libs/revealjs/dist/theme/quarto.css">
  <link href="index_files/libs/revealjs/plugin/quarto-line-highlight/line-highlight.css" rel="stylesheet">
  <link href="index_files/libs/revealjs/plugin/reveal-menu/menu.css" rel="stylesheet">
  <link href="index_files/libs/revealjs/plugin/reveal-menu/quarto-menu.css" rel="stylesheet">
  <link href="index_files/libs/revealjs/plugin/quarto-support/footer.css" rel="stylesheet">
  <style type="text/css">

  .callout {
    margin-top: 1em;
    margin-bottom: 1em;  
    border-radius: .25rem;
  }

  .callout.callout-style-simple { 
    padding: 0em 0.5em;
    border-left: solid #acacac .3rem;
    border-right: solid 1px silver;
    border-top: solid 1px silver;
    border-bottom: solid 1px silver;
    display: flex;
  }

  .callout.callout-style-default {
    border-left: solid #acacac .3rem;
    border-right: solid 1px silver;
    border-top: solid 1px silver;
    border-bottom: solid 1px silver;
  }

  .callout .callout-body-container {
    flex-grow: 1;
  }

  .callout.callout-style-simple .callout-body {
    font-size: 1rem;
    font-weight: 400;
  }

  .callout.callout-style-default .callout-body {
    font-size: 0.9rem;
    font-weight: 400;
  }

  .callout.callout-titled.callout-style-simple .callout-body {
    margin-top: 0.2em;
  }

  .callout:not(.callout-titled) .callout-body {
      display: flex;
  }

  .callout:not(.no-icon).callout-titled.callout-style-simple .callout-content {
    padding-left: 1.6em;
  }

  .callout.callout-titled .callout-header {
    padding-top: 0.2em;
    margin-bottom: -0.2em;
  }

  .callout.callout-titled .callout-title  p {
    margin-top: 0.5em;
    margin-bottom: 0.5em;
  }
    
  .callout.callout-titled.callout-style-simple .callout-content  p {
    margin-top: 0;
  }

  .callout.callout-titled.callout-style-default .callout-content  p {
    margin-top: 0.7em;
  }

  .callout.callout-style-simple div.callout-title {
    border-bottom: none;
    font-size: .9rem;
    font-weight: 600;
    opacity: 75%;
  }

  .callout.callout-style-default  div.callout-title {
    border-bottom: none;
    font-weight: 600;
    opacity: 85%;
    font-size: 0.9rem;
    padding-left: 0.5em;
    padding-right: 0.5em;
  }

  .callout.callout-style-default div.callout-content {
    padding-left: 0.5em;
    padding-right: 0.5em;
  }

  .callout.callout-style-simple .callout-icon::before {
    height: 1rem;
    width: 1rem;
    display: inline-block;
    content: "";
    background-repeat: no-repeat;
    background-size: 1rem 1rem;
  }

  .callout.callout-style-default .callout-icon::before {
    height: 0.9rem;
    width: 0.9rem;
    display: inline-block;
    content: "";
    background-repeat: no-repeat;
    background-size: 0.9rem 0.9rem;
  }

  .callout-title {
    display: flex
  }
    
  .callout-icon::before {
    margin-top: 1rem;
    padding-right: .5rem;
  }

  .callout.no-icon::before {
    display: none !important;
  }

  .callout.callout-titled .callout-body > .callout-content > :last-child {
    margin-bottom: 0.5rem;
  }

  .callout.callout-titled .callout-icon::before {
    margin-top: .5rem;
    padding-right: .5rem;
  }

  .callout:not(.callout-titled) .callout-icon::before {
    margin-top: 1rem;
    padding-right: .5rem;
  }

  /* Callout Types */

  div.callout-note {
    border-left-color: #4582ec !important;
  }

  div.callout-note .callout-icon::before {
    background-image: url('data:image/png;base64,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');
  }

  div.callout-note.callout-style-default .callout-title {
    background-color: #dae6fb
  }

  div.callout-important {
    border-left-color: #d9534f !important;
  }

  div.callout-important .callout-icon::before {
    background-image: url('data:image/png;base64,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');
  }

  div.callout-important.callout-style-default .callout-title {
    background-color: #f7dddc
  }

  div.callout-warning {
    border-left-color: #f0ad4e !important;
  }

  div.callout-warning .callout-icon::before {
    background-image: url('data:image/png;base64,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');
  }

  div.callout-warning.callout-style-default .callout-title {
    background-color: #fcefdc
  }

  div.callout-tip {
    border-left-color: #02b875 !important;
  }

  div.callout-tip .callout-icon::before {
    background-image: url('data:image/png;base64,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');
  }

  div.callout-tip.callout-style-default .callout-title {
    background-color: #ccf1e3
  }

  div.callout-caution {
    border-left-color: #fd7e14 !important;
  }

  div.callout-caution .callout-icon::before {
    background-image: url('data:image/png;base64,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');
  }

  div.callout-caution.callout-style-default .callout-title {
    background-color: #ffe5d0
  }

  </style>
  <style type="text/css">
    .reveal div.sourceCode {
      margin: 0;
      overflow: auto;
    }
    .reveal div.hanging-indent {
      margin-left: 1em;
      text-indent: -1em;
    }
    .reveal .slide:not(.center) {
      height: 100%;
      overflow-y: auto;
    }
    .reveal .slide.scrollable {
      overflow-y: auto;
    }
    .reveal .footnotes {
      height: 100%;
      overflow-y: auto;
    }
    .reveal .slide .absolute {
      position: absolute;
      display: block;
    }
    .reveal .footnotes ol {
      counter-reset: ol;
      list-style-type: none; 
      margin-left: 0;
    }
    .reveal .footnotes ol li:before {
      counter-increment: ol;
      content: counter(ol) ". "; 
    }
    .reveal .footnotes ol li > p:first-child {
      display: inline-block;
    }
    .reveal .slide ul,
    .reveal .slide ol {
      margin-bottom: 0.5em;
    }
    .reveal .slide ul li,
    .reveal .slide ol li {
      margin-top: 0.4em;
      margin-bottom: 0.2em;
    }
    .reveal .slide ul[role="tablist"] li {
      margin-bottom: 0;
    }
    .reveal .slide ul li > *:first-child,
    .reveal .slide ol li > *:first-child {
      margin-block-start: 0;
    }
    .reveal .slide ul li > *:last-child,
    .reveal .slide ol li > *:last-child {
      margin-block-end: 0;
    }
    .reveal .slide .columns:nth-child(3) {
      margin-block-start: 0.8em;
    }
    .reveal blockquote {
      box-shadow: none;
    }
    .reveal .tippy-content>* {
      margin-top: 0.2em;
      margin-bottom: 0.7em;
    }
    .reveal .tippy-content>*:last-child {
      margin-bottom: 0.2em;
    }
    .reveal .slide > img.stretch.quarto-figure-center,
    .reveal .slide > img.r-stretch.quarto-figure-center {
      display: block;
      margin-left: auto;
      margin-right: auto; 
    }
    .reveal .slide > img.stretch.quarto-figure-left,
    .reveal .slide > img.r-stretch.quarto-figure-left  {
      display: block;
      margin-left: 0;
      margin-right: auto; 
    }
    .reveal .slide > img.stretch.quarto-figure-right,
    .reveal .slide > img.r-stretch.quarto-figure-right  {
      display: block;
      margin-left: auto;
      margin-right: 0; 
    }
  </style>
</head>
<body class="quarto-dark">
  <div class="reveal">
    <div class="slides">

<section id="title-slide" data-background-image="LOADSTAR Background image.jpg" data-background-opacity="0.3" data-background-size="contain" class="quarto-title-block center">
  <h1 class="title">Treat-to-Target or High-Intensity Statin in Coronary Artery Disease</h1>
  <p class="subtitle">Tailored approach for lipid lowering</p>

<div class="quarto-title-authors">
<div class="quarto-title-author">
<div class="quarto-title-author-name">
Christopher Shin 
</div>
</div>
</div>

</section>
<section id="glossary_1" class="slide level2">
<h2>Glossary_1</h2>
<ul>
<li><strong>Coronary artery</strong> : 관상동맥; 심장에 혈액을 공급하는 동맥<br><br></li>
<li><strong>Coronary artery disease(CAD)</strong> : 관상동맥질환; 관상동맥이 막히거나 수축하여 심장으로의 혈액 공급이 어려운 질환군. 대개 죽상동맥경화가 원인임.<br><br></li>
<li><strong>Atherosclerotic cardiovascular disease(ASCVD)</strong> : 동맥경화성 심혈관질환; 죽상동맥경화로 인해 발생한 심혈관 질환군으로, 대개 이상지질혈증이 원인임. 관상동맥질환, 뇌혈관질환, 말초혈관질환, 대동맥류, 장허혈 등이 포함됨.<br><br></li>
</ul>
</section>
<section id="glossary_2" class="slide level2">
<h2>Glossary_2</h2>
<ul>
<li><strong>Statin</strong> : 스타틴; 콜레스테롤 합성 효소를 억제하여 혈중 LDL-C 농도를 낮추는 약. <br><br></li>
<li><strong>Low-density lipoprotein cholesterol(LDL-C)</strong> : 간에서 조직 말단, 혈관으로 운반되는 콜레스테롤.</li>
</ul>
</section>
<section id="background_1" class="slide level2">
<h2>Background_1</h2>
<ul>
<li>ASCVD 환자군에서 statin 사용으로 인한 LDL-C 감소는 일차예방, 이차예방 효과가 있다. <br><br></li>
<li>게다가, 현재까지의 연구결과로는 LDL-C를 낮추면 낮출수록 ASCVD 위험이 계속 줄어들었다. <br><br></li>
<li>따라서 여러 기관에서 <strong>초기 LDL-C를 50% 이상 감소시키는 것을 목표로 한 고강도 statin 사용을 권고</strong>하였다.<br><br></li>
<li>그러나 statin에 대한 반응은 <strong>개인차</strong>가 있고, 지속적인 고강도 statin 치료는 <strong>근육, 간, 콩팥</strong>에 해롭다.<br><br></li>
</ul>
</section>
<section id="background_2" class="slide level2">
<h2>Background_2</h2>
<ul>
<li>이에 중간 강도 statin으로 시작하여, <strong>특정 LDL-C 농도까지 약물 용량을 조절하는 대안</strong>이 (treat-to-target) 제시되었지만,<br><br></li>
<li>아직 대안의 근거가 부족하고, <strong>두 치료법을 직접 비교한 (head-to-head) 연구가 없는 실정이다.</strong><br><br></li>
<li>따라서 저자들은 <strong>ASCVD 환자들의 이차 예방</strong>의 측면에서, <strong>treat-to-target strategy가 high-intensity strategy에 비하여 열등하지 않음</strong>을 검증하기 위해 <strong>LOADSTAR</strong> trial을 시행하였다.</li>
</ul>
</section>
<section>
<section id="method" class="title-slide slide level1 center">
<h1>Method</h1>

</section>
<section id="study-design" class="slide level2">
<h2>Study design</h2>
<ul>
<li>Investigator-initiated, Prospective, Multicenter, Randomized, Open-label, Noninferiority trial <br><br></li>
<li>한국의 12개 기관에서 시행</li>
</ul>
</section>
<section id="patients" class="slide level2">
<h2>Patients</h2>
<ul>
<li><strong>선정기준</strong>: 임상적으로 CAD를 진단받은 19세 이상의 환자들 <br> (연구자들은 ASCVD 고위험군으로 CAD 환자군을 선정하였다) <br><br></li>
<li><strong>CAD</strong>는 다음 질환들을 포함함; 안전형 협심증, 불안정 협심증, NSTEMI, STEMI <br><br></li>
<li><strong>제외기준</strong>: Statin 병용 불가 약제 복용 중, 부작용 고위험군, 기대여명 3년 이하 등 <br><br></li>
</ul>
</section>
<section id="randomization-and-procedures" class="slide level2">
<h2>Randomization and Procedures</h2>
<div class="panel-tabset">
<ul id="tabset-1" class="panel-tabset-tabby"><li><a data-tabby-default="" href="#tabset-1-1">Random</a></li><li><a href="#tabset-1-2">Statin intensity</a></li><li><a href="#tabset-1-3">Arm_1</a></li><li><a href="#tabset-1-4">Arm_2</a></li></ul>
<div class="tab-content">
<div id="tabset-1-1">
<ul>
<li>Treat-to-target, high-intensity 군에 <strong>1:1 랜덤 배정</strong>함. <br><br></li>
<li>각 군은 다시 복용할 statin 종류(rosuvastatin, atorvastatin)에 따라 <strong>1:1 랜덤 배정</strong>함.</li>
<li>LDL-C 초기 농도, 당뇨, 급성 관상동맥 증후군에 따라 층화함.</li>
</ul>
</div>
<div id="tabset-1-2">
<ul>
<li>statin 강도는 2013 ACC/AHA 지침을 기준으로 함. <br><br></li>
<li>고강도: Rosuvastatin 20mg, Atorvastatin 40mg <br><br></li>
<li>중간 강도: Rosuvastatin 10mg, Atorvastatin 20mg <br><br></li>
</ul>
</div>
<div id="tabset-1-3">
<ul>
<li>Treat-to-target 군의 치료 목표는 50mg/dL &lt; LDL-C &lt; 70mg/dL <br><br></li>
<li>statin 복용 경험이 없다면 중간 강도로 시작함.<br><br></li>
<li>statin을 복용 중이라면 치료 목표에 도달하도록 조절함(titration) <br><br></li>
<li>Ezetimibe 등 statin 외 지질강하제 복용은 권고하지 않음.</li>
</ul>
</div>
<div id="tabset-1-4">
<ul>
<li>High-intensity 군은 LDL-C 수치와 무관하게 고강도 statin 지속.</li>
</ul>
</div>
</div>
</div>
</section>
<section id="primary-endpoint" class="slide level2">
<h2>Primary Endpoint</h2>
<ul>
<li><strong>Major Adverse Cardiac and Cerebrovascular Event(MACCE)</strong>; 다음 4가지 요소들의 합으로 표현됨.<br><br></li>
<li><strong>Death</strong> (사망) + <strong>Myocardial infarction</strong> (심근경색) + <strong>Stroke</strong> (뇌졸중) + <strong>Revascularization</strong> (재혈관화)</li>
</ul>
</section>
<section id="secondary-endpoint" class="slide level2">
<h2>Secondary Endpoint</h2>
<ul>
<li><strong>이상 사례</strong>: 당뇨, 심부전, 혈전증, 신부전, 백내장 등<br><br></li>
<li><strong>검사 결과 이상</strong>: 간, 근육, 콩팥 표지자</li>
</ul>
</section>
<section id="follow-up" class="slide level2">
<h2>Follow up</h2>
<ul>
<li>6주 + 3, 6, 12, 24, <strong>36개월</strong> <br><br></li>
<li>지질 상태, 부작용 관련 지표는 6주 + 12, 24, 36개월에 관찰함.</li>
</ul>
</section>
<section id="sample-size" class="slide level2">
<h2>Sample Size</h2>
<ul>
<li>각 군 3년 MACCE 누적 발생률을 12%로 가정함.</li>
<li>Noninferiority margin 3.0%</li>
<li>검정력 80%</li>
<li>단측검정 1종 오류 확률 2.5%</li>
<li>탈락율 15%</li>
<li><strong>최종 4400명, 각 군 2200명</strong></li>
</ul>
</section>
<section id="statistical-analysis_1" class="slide level2">
<h2>Statistical analysis_1</h2>
<ul>
<li>범주형 변수 -&gt; N(%); Chi-square test OR Fisher’s exact test <br><br></li>
<li>연속변수 -&gt; Mean ± SD OR Median(IQR); T-test OR Mann-Whitney U test <br><br></li>
<li>Primary endpoint -&gt; Log rank test, Cox proportional-hazards regression <br><br></li>
<li>Noninferiority는 두 군 MACCE 누적발생률 차이의 단측 97.5% CI 상한 &lt; 3.0% 일 때 입증</li>
</ul>
</section>
<section id="statistical-analysis_2" class="slide level2">
<h2>Statistical analysis_2</h2>
<ul>
<li><strong>Intention-to-treat (ITT)</strong> (per-protocol 분석도 시행) <br><br></li>
<li>Multiple comparison 보정은 계획하지 않음. <br><br></li>
<li>Endpoint 결측치는 제거하고, 그 외는 분석 대상 아닐 때만 포함함.</li>
</ul>
</section>
<section id="study-design-1" class="slide level2">
<h2>Study design</h2>
<div class="panel-tabset">
<ul id="tabset-2" class="panel-tabset-tabby"><li><a data-tabby-default="" href="#tabset-2-1">Figure</a></li></ul>
<div class="tab-content">
<div id="tabset-2-1">
<p><img src="LOADSTAR Study design.png"></p>
</div>
</div>
</div>
</section></section>
<section>
<section id="results" class="title-slide slide level1 center">
<h1>Results</h1>

</section>
<section id="baseline-characteristic" class="slide level2">
<h2>Baseline characteristic</h2>
<ul>
<li>2016/09/09 ~ 2019/11/27</li>
<li>무작위화 당시 진단받거나 시술/수술받은 지 1년이 넘은 사람: 75% <br><br></li>
<li>고강도, 중간 강도 statin 치료를 받던 사람: 25%, 57%</li>
</ul>
</section>
<section id="flow-diagram-baseline" class="slide level2">
<h2>Flow diagram, Baseline</h2>
<div class="panel-tabset">
<ul id="tabset-3" class="panel-tabset-tabby"><li><a data-tabby-default="" href="#tabset-3-1">Figure 1</a></li><li><a href="#tabset-3-2">Table 1</a></li></ul>
<div class="tab-content">
<div id="tabset-3-1">
<p><img src="LOADSTAR Figure 1.png"></p>
</div>
<div id="tabset-3-2">
<p><img src="LOADSTAR Table 1.png"></p>
</div>
</div>
</div>
</section>
<section id="lipid-lowering" class="slide level2">
<h2>Lipid lowering</h2>
<ul>
<li>Treat-to-target 군은 1, 2, 3년 째 각각 <strong>53%, 55%, 56%</strong>가 고강도 statin 처방받음.<br><br></li>
<li>High-intensity 군은 1, 2, 3년 째 각각 <strong>93%, 91%, 89%</strong>가 고강도 statin 처방받음.<br><br></li>
<li>Ezetimibe은 Treat-to-target 군에서 강하게 권고하지 않았음에도, 더 많이 사용함.</li>
</ul>
</section>
<section id="lipid-lowering-1" class="slide level2">
<h2>Lipid lowering</h2>
<div class="panel-tabset">
<ul id="tabset-4" class="panel-tabset-tabby"><li><a data-tabby-default="" href="#tabset-4-1">Figure 2</a></li></ul>
<div class="tab-content">
<div id="tabset-4-1">
<p><img src="LOADSTAR Figure 2.png"></p>
</div>
</div>
</div>
</section>
<section id="ldl-c-level" class="slide level2">
<h2>LDL-C level</h2>
<ul>
<li><strong>6주: Treat-to-target 군의 LDL-C 수치가 유의미하게 더 높았음.</strong></li>
<li><strong>전체 기간: 두 군의 LDL-C 수치에 유의미한 차이 없음.</strong> (69.1mg/dL vs 68.4mg/dL; p=0.21)<br><br></li>
<li>목표 도달: Treat-to-target 군의 목표 도달율이 6주, 3개월에 유의미하게 낮았음.</li>
</ul>
</section>
<section id="endpoint" class="slide level2">
<h2>Endpoint</h2>
<ul>
<li>Primary: <strong>Treat-to-target 군, High-intensity 군의 MACCE 누적발생률이 각각 8.1%, 8.7%</strong>로 나타남.<br> -0.6%pp; 97.5% CI 상한 1.1pp, <strong>p-value &lt; 0.001</strong> <br><br></li>
<li>Secondary: 두 군간 유의미한 차이 없었다.</li>
<li>그러나 사후 검정 결과 <strong>당뇨 발생 + 간/근육/콩팥 독성</strong>의 합은 <strong>Treat-to-target 군에서 유의미하게 낮았다.</strong> (6.1% vs 8.2%; p-value = 0.009)</li>
</ul>
</section>
<section id="ldl-c-and-endpoints" class="slide level2">
<h2>LDL-C and Endpoints</h2>
<div class="panel-tabset">
<ul id="tabset-5" class="panel-tabset-tabby"><li><a data-tabby-default="" href="#tabset-5-1">Figure 3</a></li><li><a href="#tabset-5-2">Table 2</a></li></ul>
<div class="tab-content">
<div id="tabset-5-1">
<p><img src="LOADSTAR Figure 3.png"></p>
</div>
<div id="tabset-5-2">
<p><img src="LOADSTAR Table 2.png"></p>
</div>
</div>
</div>
</section>
<section id="conclusion" class="slide level2">
<h2>Conclusion</h2>
<ul>
<li><strong>LOADSTAR trial은 36개월의 관찰 결과, CAD 환자를 대상으로 MACCE 발생의 측면에서 treat-to-target strategy가 high-intensity strategy에 비해 열등하지 않음을 보였다.</strong></li>
</ul>
</section>
<section id="discussion_1" class="slide level2">
<h2>Discussion_1</h2>
<ul>
<li><strong>낮은 LDL-C 목표 달성율은 (약 60%) statin 외 지질강하제 병용을 권고하지 않았기 때문</strong>인 것으로 보인다. 본 연구의 시작 시점에는 병용 요법의 근거가 부족했으나, 현재는 흔하게 사용되는 추세다. <br><br></li>
</ul>
</section>
<section id="discussion_2" class="slide level2">
<h2>Discussion_2</h2>
<ul>
<li>Treat-to-target 군과 High-intensity 군의 <strong>고강도 statin 사용</strong>에는 큰 차이가 있었으나 (54% vs 92%) <strong>치료 성적</strong>은 차이가 없었다. <br><br></li>
<li>이는 treat-to-target strategy가 <strong>개인 치료 반응 차이를 고려한 치료법</strong>임을 의미한다. 즉, 저강도 statin 요법에도 반응을 보이는 환자에게는 부작용을 감수하며 고강도 statin 요법을 사용할 필요가 없다. <br><br></li>
<li>Secondary endpoint가 treat-to-target 군에서 낮게 나타난 경향은 <strong>treat-to-target strategy가 고강도 statin 요법의 부작용으로부터 비교적 안전함</strong>을 시사한다. <br><br></li>
<li>실제로 2013 ACC/AHA 지침에서 고정용량 용법을 권고한 후 부작용 때문에 고강도 statin 요법을 중단하는 경우가 많아졌다.</li>
</ul>
</section>
<section id="discussion_3" class="slide level2">
<h2>Discussion_3</h2>
<ul>
<li>다만 treat-to-target strategy에서 유의할 점은 다음과 같다.<br><br></li>
<li><strong>LDL-C 목표치가 확실하지 않다.</strong> 본 연구는 70mg/dL 이하를 기준으로 삼았지만, 최근 유럽에서는 55mg/dL 이하를 권고했다.<br><br></li>
<li><strong>LDL-C 목표치 도달이 어렵다.</strong> 본 연구의 LDL-C 목표치 도달율은 treat-to-target 군에서 항상 낮았다. (2년 시점 제외)<br><br></li>
<li><strong>LDL-C 목표치 도달까지 오래 걸린다.</strong> 이 때문에 target-to-treat 군의 statin 시작 강도 역시 초기 LDL-C 수치에 맞춰 조절하는 전략이 필요할 수 있다.</li>
</ul>
</section>
<section id="limits_1" class="slide level2">
<h2>Limits_1</h2>
<ul>
<li>의사가 statin 용법을 안 채로 치료를 시행했다 <strong>(open-label)</strong>.<br><br></li>
<li><strong>MACCE 누적발생률이 예상보다 낮아</strong> (12% vs 8.1~8.7%) 연구가 <strong>underpowered</strong> 됐을 가능성이 있다. <br><br></li>
<li><strong>MACCE 누적발생률이 낮아</strong> 비교가 어려울 수 있다.</li>
</ul>
</section>
<section id="limits_2" class="slide level2">
<h2>Limits_2</h2>
<ul>
<li>CAD 환자만을 대상으로 했기 때문에, <strong>다른 환자군</strong>을 대상으로 한 추가 연구가 필요하다. <br><br></li>
<li><strong>LDL-C 목표치 도달율이 낮아</strong> 치료의 적절성이 의심된다. (제한적인 병용 요법)<br><br></li>
<li>3년의 추적관찰은 짧았을 수도 있다.</li>
</ul>
</section>
<section id="correspondence_1" class="slide level2">
<h2>Correspondence_1</h2>
<ul>
<li><p>Dr.&nbsp;Kawada: ApoE 변이와 같은 <strong>유전적 요소</strong>가 <strong>교란변수</strong>로 작용했을 가능성이 있다. 유전적 요소가 statin에 대한 반응율과 CAD 발생에 모두 영향을 미치기 때문이다. <br><br></p></li>
<li><p>Authors: 유전적 요소가 중요함을 인정한다. 그러나 약물유전학적 생체표지자를 검사해야 한다는 합의나 지침은 없다.</p></li>
</ul>
</section>
<section id="correspondence_2" class="slide level2">
<h2>Correspondence_2</h2>
<ul>
<li><p>Dr.&nbsp;Kawada: 표본 내 <strong>성별 차이</strong>에 대한 언급이 없다. 남자가 3172명, 여자가 1228명 참여했고, 여자는 <strong>이상지질혈증 위험이 높은 폐경 후 여성</strong>이 대부분이었다. <br><br></p></li>
<li><p>Authors: 성별의 영향을 주의 깊게 다뤄야 함을 인정하고, 후속 연구가 필요하다. 그러나 본 연구를 성별로 층화해서 분석해도 결과에 차이는 없고, 본 연구는 선행 연구들보다 여성 비율이 높다.</p></li>
</ul>
<div class="footer footer-default">
<p>LOADSTAR</p>
</div>
</section></section>
    </div>
  </div>

  <script>window.backupDefine = window.define; window.define = undefined;</script>
  <script src="index_files/libs/revealjs/dist/reveal.js"></script>
  <!-- reveal.js plugins -->
  <script src="index_files/libs/revealjs/plugin/quarto-line-highlight/line-highlight.js"></script>
  <script src="index_files/libs/revealjs/plugin/pdf-export/pdfexport.js"></script>
  <script src="index_files/libs/revealjs/plugin/reveal-menu/menu.js"></script>
  <script src="index_files/libs/revealjs/plugin/reveal-menu/quarto-menu.js"></script>
  <script src="index_files/libs/revealjs/plugin/quarto-support/support.js"></script>
  

  <script src="index_files/libs/revealjs/plugin/notes/notes.js"></script>
  <script src="index_files/libs/revealjs/plugin/search/search.js"></script>
  <script src="index_files/libs/revealjs/plugin/zoom/zoom.js"></script>
  <script src="index_files/libs/revealjs/plugin/math/math.js"></script>
  <script>window.define = window.backupDefine; window.backupDefine = undefined;</script>

  <script>

      // Full list of configuration options available at:
      // https://revealjs.com/config/
      Reveal.initialize({
'controlsAuto': true,
'previewLinksAuto': false,
'smaller': false,
'pdfSeparateFragments': false,
'autoAnimateEasing': "ease",
'autoAnimateDuration': 1,
'autoAnimateUnmatched': true,
'menu': {"side":"left","useTextContentForMissingTitles":true,"markers":false,"loadIcons":false,"custom":[{"title":"Tools","icon":"<i class=\"fas fa-gear\"></i>","content":"<ul class=\"slide-menu-items\">\n<li class=\"slide-tool-item active\" data-item=\"0\"><a href=\"#\" onclick=\"RevealMenuToolHandlers.fullscreen(event)\"><kbd>f</kbd> Fullscreen</a></li>\n<li class=\"slide-tool-item\" data-item=\"1\"><a href=\"#\" onclick=\"RevealMenuToolHandlers.speakerMode(event)\"><kbd>s</kbd> Speaker View</a></li>\n<li class=\"slide-tool-item\" data-item=\"2\"><a href=\"#\" onclick=\"RevealMenuToolHandlers.overview(event)\"><kbd>o</kbd> Slide Overview</a></li>\n<li class=\"slide-tool-item\" data-item=\"3\"><a href=\"#\" onclick=\"RevealMenuToolHandlers.togglePdfExport(event)\"><kbd>e</kbd> PDF Export Mode</a></li>\n<li class=\"slide-tool-item\" data-item=\"4\"><a href=\"#\" onclick=\"RevealMenuToolHandlers.keyboardHelp(event)\"><kbd>?</kbd> Keyboard Help</a></li>\n</ul>"}],"openButton":true},
'smaller': false,
 
        // Display controls in the bottom right corner
        controls: false,

        // Help the user learn the controls by providing hints, for example by
        // bouncing the down arrow when they first encounter a vertical slide
        controlsTutorial: false,

        // Determines where controls appear, "edges" or "bottom-right"
        controlsLayout: 'edges',

        // Visibility rule for backwards navigation arrows; "faded", "hidden"
        // or "visible"
        controlsBackArrows: 'faded',

        // Display a presentation progress bar
        progress: true,

        // Display the page number of the current slide
        slideNumber: 'c/t',

        // 'all', 'print', or 'speaker'
        showSlideNumber: 'all',

        // Add the current slide number to the URL hash so that reloading the
        // page/copying the URL will return you to the same slide
        hash: true,

        // Start with 1 for the hash rather than 0
        hashOneBasedIndex: false,

        // Flags if we should monitor the hash and change slides accordingly
        respondToHashChanges: true,

        // Push each slide change to the browser history
        history: true,

        // Enable keyboard shortcuts for navigation
        keyboard: true,

        // Enable the slide overview mode
        overview: true,

        // Disables the default reveal.js slide layout (scaling and centering)
        // so that you can use custom CSS layout
        disableLayout: false,

        // Vertical centering of slides
        center: false,

        // Enables touch navigation on devices with touch input
        touch: true,

        // Loop the presentation
        loop: false,

        // Change the presentation direction to be RTL
        rtl: false,

        // see https://revealjs.com/vertical-slides/#navigation-mode
        navigationMode: 'linear',

        // Randomizes the order of slides each time the presentation loads
        shuffle: false,

        // Turns fragments on and off globally
        fragments: true,

        // Flags whether to include the current fragment in the URL,
        // so that reloading brings you to the same fragment position
        fragmentInURL: false,

        // Flags if the presentation is running in an embedded mode,
        // i.e. contained within a limited portion of the screen
        embedded: false,

        // Flags if we should show a help overlay when the questionmark
        // key is pressed
        help: true,

        // Flags if it should be possible to pause the presentation (blackout)
        pause: true,

        // Flags if speaker notes should be visible to all viewers
        showNotes: false,

        // Global override for autoplaying embedded media (null/true/false)
        autoPlayMedia: null,

        // Global override for preloading lazy-loaded iframes (null/true/false)
        preloadIframes: null,

        // Number of milliseconds between automatically proceeding to the
        // next slide, disabled when set to 0, this value can be overwritten
        // by using a data-autoslide attribute on your slides
        autoSlide: 0,

        // Stop auto-sliding after user input
        autoSlideStoppable: true,

        // Use this method for navigation when auto-sliding
        autoSlideMethod: null,

        // Specify the average time in seconds that you think you will spend
        // presenting each slide. This is used to show a pacing timer in the
        // speaker view
        defaultTiming: null,

        // Enable slide navigation via mouse wheel
        mouseWheel: false,

        // The display mode that will be used to show slides
        display: 'block',

        // Hide cursor if inactive
        hideInactiveCursor: true,

        // Time before the cursor is hidden (in ms)
        hideCursorTime: 5000,

        // Opens links in an iframe preview overlay
        previewLinks: false,

        // Transition style (none/fade/slide/convex/concave/zoom)
        transition: 'slide',

        // Transition speed (default/fast/slow)
        transitionSpeed: 'default',

        // Transition style for full page slide backgrounds
        // (none/fade/slide/convex/concave/zoom)
        backgroundTransition: 'none',

        // Number of slides away from the current that are visible
        viewDistance: 3,

        // Number of slides away from the current that are visible on mobile
        // devices. It is advisable to set this to a lower number than
        // viewDistance in order to save resources.
        mobileViewDistance: 2,

        // The "normal" size of the presentation, aspect ratio will be preserved
        // when the presentation is scaled to fit different resolutions. Can be
        // specified using percentage units.
        width: 1050,

        height: 700,

        // Factor of the display size that should remain empty around the content
        margin: 0.1,

        math: {
          mathjax: 'https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.0/MathJax.js',
          config: 'TeX-AMS_HTML-full',
          tex2jax: {
            inlineMath: [['\\(','\\)']],
            displayMath: [['\\[','\\]']],
            balanceBraces: true,
            processEscapes: false,
            processRefs: true,
            processEnvironments: true,
            preview: 'TeX',
            skipTags: ['script','noscript','style','textarea','pre','code'],
            ignoreClass: 'tex2jax_ignore',
            processClass: 'tex2jax_process'
          },
        },

        // reveal.js plugins
        plugins: [QuartoLineHighlight, PdfExport, RevealMenu, QuartoSupport,

          RevealMath,
          RevealNotes,
          RevealSearch,
          RevealZoom
        ]
      });
    </script>
    <script id="quarto-html-after-body" type="application/javascript">
    window.document.addEventListener("DOMContentLoaded", function (event) {
      const toggleBodyColorMode = (bsSheetEl) => {
        const mode = bsSheetEl.getAttribute("data-mode");
        const bodyEl = window.document.querySelector("body");
        if (mode === "dark") {
          bodyEl.classList.add("quarto-dark");
          bodyEl.classList.remove("quarto-light");
        } else {
          bodyEl.classList.add("quarto-light");
          bodyEl.classList.remove("quarto-dark");
        }
      }
      const toggleBodyColorPrimary = () => {
        const bsSheetEl = window.document.querySelector("link#quarto-bootstrap");
        if (bsSheetEl) {
          toggleBodyColorMode(bsSheetEl);
        }
      }
      toggleBodyColorPrimary();  
      const tabsets =  window.document.querySelectorAll(".panel-tabset-tabby")
      tabsets.forEach(function(tabset) {
        const tabby = new Tabby('#' + tabset.id);
      });
      const isCodeAnnotation = (el) => {
        for (const clz of el.classList) {
          if (clz.startsWith('code-annotation-')) {                     
            return true;
          }
        }
        return false;
      }
      const clipboard = new window.ClipboardJS('.code-copy-button', {
        text: function(trigger) {
          const codeEl = trigger.previousElementSibling.cloneNode(true);
          for (const childEl of codeEl.children) {
            if (isCodeAnnotation(childEl)) {
              childEl.remove();
            }
          }
          return codeEl.innerText;
        }
      });
      clipboard.on('success', function(e) {
        // button target
        const button = e.trigger;
        // don't keep focus
        button.blur();
        // flash "checked"
        button.classList.add('code-copy-button-checked');
        var currentTitle = button.getAttribute("title");
        button.setAttribute("title", "Copied!");
        let tooltip;
        if (window.bootstrap) {
          button.setAttribute("data-bs-toggle", "tooltip");
          button.setAttribute("data-bs-placement", "left");
          button.setAttribute("data-bs-title", "Copied!");
          tooltip = new bootstrap.Tooltip(button, 
            { trigger: "manual", 
              customClass: "code-copy-button-tooltip",
              offset: [0, -8]});
          tooltip.show();    
        }
        setTimeout(function() {
          if (tooltip) {
            tooltip.hide();
            button.removeAttribute("data-bs-title");
            button.removeAttribute("data-bs-toggle");
            button.removeAttribute("data-bs-placement");
          }
          button.setAttribute("title", currentTitle);
          button.classList.remove('code-copy-button-checked');
        }, 1000);
        // clear code selection
        e.clearSelection();
      });
      function tippyHover(el, contentFn) {
        const config = {
          allowHTML: true,
          content: contentFn,
          maxWidth: 500,
          delay: 100,
          arrow: false,
          appendTo: function(el) {
              return el.closest('section.slide') || el.parentElement;
          },
          interactive: true,
          interactiveBorder: 10,
          theme: 'light-border',
          placement: 'bottom-start'
        };
          config['offset'] = [0,0];
          config['maxWidth'] = 700;
        window.tippy(el, config); 
      }
      const noterefs = window.document.querySelectorAll('a[role="doc-noteref"]');
      for (var i=0; i<noterefs.length; i++) {
        const ref = noterefs[i];
        tippyHover(ref, function() {
          // use id or data attribute instead here
          let href = ref.getAttribute('data-footnote-href') || ref.getAttribute('href');
          try { href = new URL(href).hash; } catch {}
          const id = href.replace(/^#\/?/, "");
          const note = window.document.getElementById(id);
          return note.innerHTML;
        });
      }
      const findCites = (el) => {
        const parentEl = el.parentElement;
        if (parentEl) {
          const cites = parentEl.dataset.cites;
          if (cites) {
            return {
              el,
              cites: cites.split(' ')
            };
          } else {
            return findCites(el.parentElement)
          }
        } else {
          return undefined;
        }
      };
      var bibliorefs = window.document.querySelectorAll('a[role="doc-biblioref"]');
      for (var i=0; i<bibliorefs.length; i++) {
        const ref = bibliorefs[i];
        const citeInfo = findCites(ref);
        if (citeInfo) {
          tippyHover(citeInfo.el, function() {
            var popup = window.document.createElement('div');
            citeInfo.cites.forEach(function(cite) {
              var citeDiv = window.document.createElement('div');
              citeDiv.classList.add('hanging-indent');
              citeDiv.classList.add('csl-entry');
              var biblioDiv = window.document.getElementById('ref-' + cite);
              if (biblioDiv) {
                citeDiv.innerHTML = biblioDiv.innerHTML;
              }
              popup.appendChild(citeDiv);
            });
            return popup.innerHTML;
          });
        }
      }
    });
    </script>
    

</body></html>